Murine animal models for preclinical islet transplantation

References

• van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91:79 - 118; http://dx.doi.org/10.1152/physrev.00003.2010; PMID: 21248163
   PubMed Web of Science ®Google Scholar
• Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012; 35:1436 - 45; http://dx.doi.org/10.2337/dc12-0063; PMID: 22723582
   PubMed Web of Science ®Google Scholar
• Eriksson O, Alavi A. Imaging the islet graft by positron emission tomography. Eur J Nucl Med Mol Imaging 2012; 39:533 - 42; http://dx.doi.org/10.1007/s00259-011-1928-4; PMID: 21932118
   PubMed Web of Science ®Google Scholar
• Eriksson O, Eich T, Sundin A, Tibell A, Tufveson G, Andersson H, et al. Positron emission tomography in clinical islet transplantation. Am J Transplant 2009; 9:2816 - 24; http://dx.doi.org/10.1111/j.1600-6143.2009.02844.x; PMID: 19845588
   PubMed Web of Science ®Google Scholar
• Crowe LA, Ris F, Nielles-Vallespin S, Speier P, Masson S, Armanet M, et al. A novel method for quantitative monitoring of transplanted islets of langerhans by positive contrast magnetic resonance imaging. Am J Transplant 2011; 11:1158 - 68; http://dx.doi.org/10.1111/j.1600-6143.2011.03559.x; PMID: 21564535
   PubMed Web of Science ®Google Scholar
• Piemonti L, Everly MJ, Maffi P, Scavini M, Poli F, Nano R, et al. Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes. Diabetes 2012; 62:1 - 9; PMID: 23274902
   PubMed Web of Science ®Google Scholar
• Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, et al. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim 2011; 45:131 - 40; http://dx.doi.org/10.1258/la.2010.010090; PMID: 21478271
   PubMed Web of Science ®Google Scholar
• Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51:216 - 26; http://dx.doi.org/10.1007/s00125-007-0886-7; PMID: 18087688
   PubMed Web of Science ®Google Scholar
• Lapierre P, Béland K, Djilali-Saiah I, Alvarez F. Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 2006; 26:82 - 9; http://dx.doi.org/10.1016/j.jaut.2005.11.001; PMID: 16380229
   PubMed Web of Science ®Google Scholar
• Muller YD, Golshayan D, Ehirchiou D, Wyss JC, Giovannoni L, Meier R, et al. Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells. Diabetes 2011; 60:2331 - 40; http://dx.doi.org/10.2337/db11-0159; PMID: 21752956
   PubMed Web of Science ®Google Scholar
• Eisenbarth GS. Type 1 diabetes: molecular, cellular and clinical immunology. Adv Exp Med Biol 2004; 552:306 - 10; PMID: 15622970
   PubMed Web of Science ®Google Scholar
• André I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A 1996; 93:2260 - 3; http://dx.doi.org/10.1073/pnas.93.6.2260; PMID: 8637860
   PubMed Web of Science ®Google Scholar
• Enghofer M, Bojunga J, Ludwig R, Oldenburg A, Bernd A, Usadel KH, et al. Lymphocyte transfer in streptozotocin-induced diabetes: adhesion of donor cells to islet endothelium. Am J Physiol 1998; 274:E928 - 35; PMID: 9612252
   PubMedGoogle Scholar
• Herold KC, Vezys V, Sun Q, Viktora D, Seung E, Reiner S, et al. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol 1996; 156:3521 - 7; PMID: 8617981
   PubMed Web of Science ®Google Scholar
• McEvoy RC, Andersson J, Sandler S, Hellerström C. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J Clin Invest 1984; 74:715 - 22; http://dx.doi.org/10.1172/JCI111487; PMID: 6088584
   PubMed Web of Science ®Google Scholar
• Müller A, Schott-Ohly P, Dohle C, Gleichmann H. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 2002; 205:35 - 50; http://dx.doi.org/10.1078/0171-2985-00109; PMID: 11999343
   PubMed Web of Science ®Google Scholar
• Imaeda A, Kaneko T, Aoki T, Kondo Y, Nagase H. DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem Toxicol 2002; 40:979 - 87; http://dx.doi.org/10.1016/S0278-6915(02)00014-5; PMID: 12065220
   PubMed Web of Science ®Google Scholar
• Leiter EH. The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr Protoc Immunol 2001; Chapter 15:9; PMID: 18432739
   PubMedGoogle Scholar
• Mathews CE, Langley SH, Leiter EH. New mouse model to study islet transplantation in insulin-dependent diabetes mellitus. Transplantation 2002; 73:1333 - 6; http://dx.doi.org/10.1097/00007890-200204270-00024; PMID: 11981430
   PubMed Web of Science ®Google Scholar
• Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, et al. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65:305 - 17; http://dx.doi.org/10.1016/0092-8674(91)90164-T; PMID: 1901764
   PubMed Web of Science ®Google Scholar
• Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991; 65:319 - 31; http://dx.doi.org/10.1016/0092-8674(91)90165-U; PMID: 1901765
   PubMed Web of Science ®Google Scholar
• Lo D, Freedman J, Hesse S, Palmiter RD, Brinster RL, Sherman LA. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol 1992; 22:1013 - 22; http://dx.doi.org/10.1002/eji.1830220421; PMID: 1348026
   PubMed Web of Science ®Google Scholar
• Christen U, Hintermann E, Holdener M, von Herrath MG. Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’ half full or half empty?. J Autoimmun 2010; 34:38 - 44; http://dx.doi.org/10.1016/j.jaut.2009.08.001; PMID: 19716269
   PubMed Web of Science ®Google Scholar
• MacGregor RR, Williams SJ, Tong PY, Kover K, Moore WV, Stehno-Bittel L. Small rat islets are superior to large islets in in vitro function and in transplantation outcomes. Am J Physiol Endocrinol Metab 2006; 290:E771 - 9; http://dx.doi.org/10.1152/ajpendo.00097.2005; PMID: 16303846
   PubMed Web of Science ®Google Scholar
• Ricordi C. Quantitative and qualitative standards for islet isolation assessment in humans and large mammals. Pancreas 1991; 6:242 - 4; http://dx.doi.org/10.1097/00006676-199103000-00018; PMID: 1679542
   PubMed Web of Science ®Google Scholar
• Huang HH, Ramachandran K, Stehno-Bittel L. A replacement for islet equivalents with improved reliability and validity. Acta Diabetol 2012; In press http://dx.doi.org/10.1007/s00592-012-0375-4; PMID: 22302191
   PubMed Web of Science ®Google Scholar
• Melzi R, Battaglia M, Draghici E, Bonifacio E, Piemonti L. Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: implication for mouse model. Transplantation 2007; 83:167 - 73; http://dx.doi.org/10.1097/01.tp.0000250659.24286.43; PMID: 17264813
   PubMed Web of Science ®Google Scholar
• Makhlouf L, Duvivier-Kali VF, Bonner-Weir S, Dieperink H, Weir GC, Sayegh MH. Importance of hyperglycemia on the primary function of allogeneic islet transplants. Transplantation 2003; 76:657 - 64; http://dx.doi.org/10.1097/01.TP.0000080881.75767.0E; PMID: 12973104
   PubMed Web of Science ®Google Scholar
• Tanabe K, Liu Y, Hasan SD, Martinez SC, Cras-Méneur C, Welling CM, et al. Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation. PLoS One 2011; 6:e18146; http://dx.doi.org/10.1371/journal.pone.0018146; PMID: 21541314
   PubMedGoogle Scholar
• Nichols CG, Remedi MS. The diabetic β-cell: hyperstimulated vs. hyperexcited. Diabetes Obes Metab 2012; 14:Suppl 3 129 - 35; http://dx.doi.org/10.1111/j.1463-1326.2012.01655.x; PMID: 22928573
   PubMedGoogle Scholar
• Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45:1161 - 7; http://dx.doi.org/10.2337/diabetes.45.9.1161; PMID: 8772716
   PubMed Web of Science ®Google Scholar
• Kawahara T, Kin T, Kashkoush S, Gala-Lopez B, Bigam DL, Kneteman NM, et al. Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation. Am J Transplant 2011; 11:2700 - 7; http://dx.doi.org/10.1111/j.1600-6143.2011.03717.x; PMID: 21883914
   PubMed Web of Science ®Google Scholar
• Contreras JL, Eckstein C, Smyth CA, Bilbao G, Vilatoba M, Ringland SE, et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 2004; 53:2804 - 14; http://dx.doi.org/10.2337/diabetes.53.11.2804; PMID: 15504960
   PubMed Web of Science ®Google Scholar
• Vriens MR, Marinelli A, Harinck HI, Zwinderman KH, van de Velde CJ. The role of allopurinol in human liver ischemia/reperfusion injury: a prospective randomized clinical trial. Hepatogastroenterology 2002; 49:1069 - 73; PMID: 12143204
   PubMed Web of Science ®Google Scholar
• Gustafson EK, Elgue G, Hughes RD, Mitry RR, Sanchez J, Haglund U, et al. The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation 2011; 91:632 - 8; http://dx.doi.org/10.1097/TP.0b013e31820ae459; PMID: 21289595
   PubMed Web of Science ®Google Scholar
• Citro A, Cantarelli E, Maffi P, Nano R, Melzi R, Mercalli A, et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J Clin Invest 2012; 122:3647 - 51; http://dx.doi.org/10.1172/JCI63089; PMID: 22996693
   PubMed Web of Science ®Google Scholar
• van Suylichem PT, Strubbe JH, Houwing H, Wolters GH, van Schilfgaarde R. Rat islet isograft function. Effect of graft volume and transplantation site. Transplantation 1994; 57:1010 - 7; PMID: 8165696
   PubMed Web of Science ®Google Scholar
• Song HJ, Xue WJ, Li Y, Tian XH, Ding XM, Feng XS, et al. Prolongation of islet graft survival using concomitant transplantation of islets and vascular endothelial cells in diabetic rats. Transplant Proc 2010; 42:2662 - 5; http://dx.doi.org/10.1016/j.transproceed.2010.06.003; PMID: 20832565
   PubMed Web of Science ®Google Scholar
• Rackham CL, Chagastelles PC, Nardi NB, Hauge-Evans AC, Jones PM, King AJ. Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia 2011; 54:1127 - 35; http://dx.doi.org/10.1007/s00125-011-2053-4; PMID: 21267536
   PubMed Web of Science ®Google Scholar
• Sordi V, Melzi R, Mercalli A, Formicola R, Doglioni C, Tiboni F, et al. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function. Stem Cells 2010; 28:140 - 51; http://dx.doi.org/10.1002/stem.314; PMID: 19924826
   PubMed Web of Science ®Google Scholar
• Sakata N, Chan NK, Chrisler J, Obenaus A, Hathout E. Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation 2010; 89:686 - 93; http://dx.doi.org/10.1097/TP.0b013e3181cb3e8d; PMID: 20101199
   PubMed Web of Science ®Google Scholar
• Melzi R, Antonioli B, Mercalli A, Battaglia M, Valle A, Pluchino S, et al. Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPC-derived tumors in mice. PLoS One 2010; 5:e10357; http://dx.doi.org/10.1371/journal.pone.0010357; PMID: 20436918
   PubMedGoogle Scholar
• Dufour JM, Lord SJ, Kin T, Rayat GR, Dixon DE, Bleackley RC, et al. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice. Cell Transplant 2008; 16:1029 - 38; http://dx.doi.org/10.3727/000000007783472417; PMID: 18351019
   PubMed Web of Science ®Google Scholar
• Wood KJ, Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012; 93:1 - 10; http://dx.doi.org/10.1097/TP.0b013e31823cab44; PMID: 22138818
   PubMed Web of Science ®Google Scholar
• Farney AC, Xenos E, Sutherland DE, Widmer M, Stephanian E, Field MJ, et al. Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. Transplant Proc 1993; 25:865 - 6; PMID: 8382881
   PubMed Web of Science ®Google Scholar
• Sandberg JO, Eizirik DL, Sandler S. IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice. Clin Exp Immunol 1997; 108:314 - 7; http://dx.doi.org/10.1046/j.1365-2249.1997.3771275.x; PMID: 9158104
   PubMed Web of Science ®Google Scholar
• McCall M, Pawlick R, Kin T, Shapiro AM. Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am J Transplant 2012; 12:322 - 9; http://dx.doi.org/10.1111/j.1600-6143.2011.03796.x; PMID: 22053751
   PubMed Web of Science ®Google Scholar
• Cantarelli E, Melzi R, Mercalli A, Sordi V, Ferrari G, Lederer CW, et al. Bone marrow as an alternative site for islet transplantation. Blood 2009; 114:4566 - 74; http://dx.doi.org/10.1182/blood-2009-03-209973; PMID: 19773545
   PubMed Web of Science ®Google Scholar
• Williams MA, Trambley J, Ha J, Adams AB, Durham MM, Rees P, et al. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000; 165:6849 - 57; PMID: 11120808
   PubMed Web of Science ®Google Scholar
• Mysliwietz J, Thierfelder S. Analysis of peripheral immune tolerance uncovers a mouse strain-dependent in situ type of graft tolerance. Eur J Immunol 1999; 29:150 - 5; http://dx.doi.org/10.1002/(SICI)1521-4141(199901)29:01<150::AID-IMMU150>3.0.CO;2-7; PMID: 9933096
   PubMed Web of Science ®Google Scholar
• van Maurik A, Wood KJ, Jones ND. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway. Transplantation 2002; 74:740 - 3; http://dx.doi.org/10.1097/00007890-200209150-00026; PMID: 12352896
   PubMed Web of Science ®Google Scholar
• Melzi R, Sanvito F, Mercalli A, Andralojc K, Bonifacio E, Piemonti L. Intrahepatic islet transplant in the mouse: functional and morphological characterization. Cell Transplant 2008; 17:1361 - 70; http://dx.doi.org/10.3727/096368908787648146; PMID: 19364073
   PubMed Web of Science ®Google Scholar
• Yoon IH, Choi SE, Kim YH, Yang SH, Park JH, Park CS, et al. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts. Transplantation 2008; 86:1352 - 60; http://dx.doi.org/10.1097/TP.0b013e31818aa43c; PMID: 19034003
   PubMed Web of Science ®Google Scholar
• Millrain M, Chandler P, Dazzi F, Scott D, Simpson E, Dyson PJ. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis. J Immunol 2001; 167:3756 - 64; PMID: 11564792
   PubMed Web of Science ®Google Scholar